Literature DB >> 11880053

The antimicrobial activity of C-reactive protein.

Alexander J Szalai1.   

Abstract

Recent studies in transgenic mice confirmed that C-reactive protein is protective against microbial pathogens. This is consistent with its ability in vitro to bind microbes, activate the complement classical pathway, and engage FcgammaRI and FcgammaRII. However, in transgenic mice protection also requires the alternative pathway of complement, and FcgammaRI is dispensable.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11880053     DOI： 10.1016/s1286-4579(01)01528-3

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  20 in total

1.  Neutrophil responses to CRP are not dependent on polymorphism of human FcgammaRIIA (R131H).

Authors:  J A Rodríguez; K B Bodman-Smith; J G Raynes
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

2.  Carbohydrate ligands of human C-reactive protein: binding of neoglycoproteins containing galactose-6-phosphate and galactose-terminated disaccharide.

Authors:  Reiko T Lee; Yuan C Lee
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

3.  Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice.

Authors:  Nicholas R Jones; Melissa A Pegues; Mark A McCrory; Steven W Kerr; Huiping Jiang; Rosemarie Sellati; Valentina Berger; Jorge Villalona; Rajvee Parikh; Mary McFarland; Lynn Pantages; Jeffrey B Madwed; Alexander J Szalai
Journal:  Arthritis Rheum       Date:  2011-09

Review 4.  C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity.

Authors:  Terry W Du Clos; Carolyn Mold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Human serum amyloid A protein inhibits hepatitis C virus entry into cells.

Authors:  Zhaohui Cai; Lei Cai; Jieyun Jiang; Kyung-Soo Chang; Deneys R van der Westhuyzen; Guangxiang Luo
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

Review 6.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

7.  Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent.

Authors:  Xian-Zhen Hu; Tyler T Wright; Nicholas R Jones; Theresa N Ramos; Gregory A Skibinski; Mark A McCrory; Scott R Barnum; Alexander J Szalai
Journal:  Autoimmune Dis       Date:  2010-10-12

Review 8.  Pentraxins, anti-pentraxin antibodies, and atherosclerosis.

Authors:  N Bassi; S Zampieri; A Ghirardello; M Tonon; M Zen; F Cozzi; A Doria
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 9.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

10.  Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?

Authors:  Virginia B Kraus; Joanne M Jordan
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.